AN ACT TO MAKE CLARIFICATIONS REGARDING THE CONDITIONS IN WHICH A PHYSICIAN ASSISTANT OR NURSE PRACTITIONER MUST CONSULT WITH A SUPERVISING PHYSICIAN PRIOR TO PRESCRIBING A TARGETED CONTROLLED SUBSTANCE. SL 2021-70. Enacted July 2, 2021. Effective October 1, 2021.
Bill H 629 (2021)Summary date: Jul 2 2021 - More information
Bill H 629 (2021-2022)Summary date: Apr 21 2021 - More information
Amends GS 90-18.1 (authorizing physician assistants to prescribe medication) and GS 90-18.2 (authorizing nurse practitioners to prescribe medication) to change the circumstances under which physician assistants or nurse practitioners must consult with the supervising physician before prescribing a targeted controlled substance to include when the patient is being treated by a facility that primarily engages in the treatment of pain by prescribing narcotic medications (previously also include a facility that advertises in any medium for any type of pain management services). Effective October 1, 2021.
© 2021 School of Government The University of North Carolina at Chapel Hill
This work is copyrighted and subject to "fair use" as permitted by federal copyright law. No portion of this publication may be reproduced or transmitted in any form or by any means without the express written permission of the publisher. Distribution by third parties is prohibited. Prohibited distribution includes, but is not limited to, posting, e-mailing, faxing, archiving in a public database, installing on intranets or servers, and redistributing via a computer network or in printed form. Unauthorized use or reproduction may result in legal action against the unauthorized user.